Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.
- DOI
- 10.1200/po.23.00299
- Published
- 2023 Sep
- Container
- JCO precision oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/po.23.00299,
title = {Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.},
author = {Özgü E and Aydin E and Adibi A and Tokat ÜM and Tutar O and Hu J and Demiray I and Kurzrock R and Demiray M},
year = {2023},
journal = {JCO precision oncology},
doi = {10.1200/po.23.00299},
url = {https://doi.org/10.1200/po.23.00299}
}RIS
TY - JOUR TI - Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview. AU - Özgü E AU - Aydin E AU - Adibi A AU - Tokat ÜM AU - Tutar O AU - Hu J AU - Demiray I AU - Kurzrock R AU - Demiray M PY - 2023 JO - JCO precision oncology DO - 10.1200/po.23.00299 UR - https://doi.org/10.1200/po.23.00299 ER -
APA
E, Ö., E, A., A, A., ÜM, T., O, T., J, H., I, D., R, K., & M, D. (2023). Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.. JCO precision oncology. https://doi.org/10.1200/po.23.00299
Source records
- pubmed · retrieved 2026-09-24T22:57:55.160Z